# Trieza Therapeutics, Inc. — Form D

Trieza Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-05. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-12-05
- Form: D
- Accession: 0001691194-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 5
- Date of first sale: 2016-11-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-275662

## Issuer

- Name: Trieza Therapeutics, Inc.
- CIK: 0001691194
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-588-4150

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Luke Evnin | Director | Watertown, MA |
| Daniel Hicklin | Director | Cambridge, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Daniel Hicklin | Executive Officer | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-12-05](https://search.stillhousedata.com/formd/0001691194-16-000001) | D | $1 | $1 |

## More

- [CIK 1691194 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1691194&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001691194-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.